lobbying_activities: 624037

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
624037	fc0adaa1-3fb1-4640-826b-0693d0552444	Q2	CAPITOL HILL CONSULTING GROUP	72053	NOVARTIS CORPORATION	2008	second_quarter	PHA	Pharmaceutical and Life Sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; The Hatch-Waxman Act; drug safety	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2008-07-09T16:07:25-04:00